Semiquantitative detection of abnormal CD44 transcripts in colon carcinomas by reverse transcription-polymerase chain reaction enzyme-linked immunosorbant assay (RT-PCR ELISA)

Molecular Diagnosis

Volumn 1, Issue 3, 1996, Pages 167-173

  Yoshida, Kazuhiro ^a   Goodison, Steve ^a   Sugino, Takashi ^a   Bolodeoku, John ^a   Churchman, Michael ^a   Warren, Bryan F ^b   Tarin, David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

CD44; Colon carcinoma; ELISA; Noninvasive detection of cancer; RT PCR

Indexed keywords

EID: 3042569429     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-8592(96)70002-4     Document Type: Article

References (3)

1. Screaton GR, Bell MV, Jackson DG, Corneilis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-12164
2. Stamenkovic I, Aruffo A, Amoiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10: 343-348
3. Heider K-H, Dammrich J, Skroch-Angel P, Muller-Hermelink H-K, Vollmers HP, Herrlich P, Ponta H: Differential expression of CD44 splice variants in intestinaland diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993;53:4197-4203